| Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 | Mar'18 | |
|---|---|---|---|---|---|---|
Revenues | ||||||
76,129 | 82,307 | 69,741 | 69,064 | 70,685 | 69,890 | |
Costs of processing and distribution | ||||||
34,642 | 37,562 | 31,737 | 31,409 | 40,645 | 36,208 | |
Gross profit | ||||||
41,487 | 44,745 | 38,004 | 37,655 | 30,040 | 33,682 | |
Expenses: | ||||||
Marketing, general and administrative | ||||||
37,107 | 38,993 | 31,883 | 29,671 | 29,266 | 28,389 | |
Research and development | ||||||
4,271 | 3,868 | 4,336 | 3,606 | 3,270 | 3,421 | |
Severance and restructuring costs | ||||||
- | - | - | 824 | 0 | 884 | |
Gain on acquisition contingency | ||||||
- | 1,590 | - | - | - | - | |
Asset impairment and abandonments | ||||||
- | - | - | 104 | 4,515 | - | |
Asset abandonments | ||||||
- | - | -15 | - | - | -129 | |
Acquisition and integration expenses | ||||||
3,209 | 1,953 | 8,957 | 1,941 | 0 | 800 | |
Cardiothoracic closure business divestiture contingency consideration | ||||||
- | - | - | 3,000 | - | - | |
Total operating expenses | ||||||
44,587 | 43,224 | 45,191 | 33,146 | 37,051 | 33,623 | |
Operating (loss) income | ||||||
-3,100 | 1,521 | -7,187 | 4,509 | -7,011 | 59 | |
Other (expense) income: | ||||||
Interest expense | ||||||
3,718 | 3,635 | 1,604 | 611 | 777 | 835 | |
Interest income | ||||||
4 | 26 | 131 | 14 | 6 | 11 | |
Loss on extinguishment of debt | ||||||
- | - | - | - | -309 | - | |
Foreign exchange loss | ||||||
-78 | -19 | -31 | -1 | -71 | 49 | |
Total other expense - net | ||||||
-3,792 | -3,628 | -1,504 | -598 | -1,151 | -775 | |
(Loss) income before income tax benefit (expense) | ||||||
-6,892 | -2,107 | -8,691 | 3,911 | -8,162 | -716 | |
Income tax benefit (expense) | ||||||
-2,040 | -2,851 | 396 | 807 | -2,702 | 249 | |
Net (loss) income | ||||||
-4,852 | 744 | -9,087 | 3,104 | -5,460 | -965 | |
Convertible preferred dividend | ||||||
- | - | - | 173 | 981 | 966 | |
Net (loss) income applicable to common shares | ||||||
-4,852 | 744 | -9,087 | 2,931 | -6,441 | -1,931 | |
Other comprehensive (loss) gain: | ||||||
Unrealized foreign currency translation loss | ||||||
-1,122 | 395 | -393 | -130 | -914 | 393 | |
Comprehensive (loss) gain | ||||||
-5,974 | 1,139 | -9,480 | 2,801 | -7,355 | -1,538 | |
Net (loss) income per common share - basic | ||||||
-0.06 | 0.01 | -0.14 | 0.05 | -0.10 | -0.03 | |
Net (loss) income per common share - diluted | ||||||
-0.06 | 0.01 | -0.14 | 0.04 | -0.10 | -0.03 | |
Weighted average shares outstanding - basic | ||||||
75,194 | 75,144 | 65,675 | 63,495 | 63,405 | 63,150 | |
Weighted average shares outstanding - diluted | ||||||
75,194 | 91,120 | 65,675 | 79,284 | 63,405 | 63,150 | |